Michael Cherny
Stock Analyst at Leerink Partners
(4.19)
# 1,570
Out of 4,698 analysts
555
Total ratings
56.9%
Success rate
5.7%
Average return
Main Sectors:
Stocks Rated by Michael Cherny
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Maintained: Buy | $240 → $292 | $248.61 | +17.45% | 39 | Aug 11, 2026 | |
| GDRX GoodRx Holdings | Maintained: Buy | $5 | $3.53 | +41.64% | 24 | Aug 6, 2026 | |
| MEDP Medpace Holdings | Maintained: Hold | $490 → $620 | $593.39 | +4.48% | 7 | Jul 23, 2026 | |
| PGNY Progyny | Maintained: Buy | $38 | $26.61 | +42.80% | 36 | Jul 22, 2026 | |
| ALGN Align Technology | Reiterated: Buy | $230 | $159.86 | +43.88% | 20 | Jun 30, 2026 | |
| CERT Certara | Reiterated: Buy | $13 → $8 | $8.13 | -1.60% | 16 | Jun 16, 2026 | |
| XRAY DENTSPLY SIRONA | Maintained: Hold | n/a | $11.43 | - | 34 | Jun 12, 2026 | |
| MDLN Medline | Maintained: Buy | $56 → $52 | $36.59 | +42.12% | 4 | Jun 12, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Hold | $125 → $145 | $163.58 | -11.36% | 17 | May 28, 2026 | |
| DOCS Doximity | Rated: Buy | $79 → $25 | $27.10 | -7.75% | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $27.82 | - | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 | $97.20 | +0.82% | 66 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $87 | $90.86 | -4.25% | 31 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $35 | $27.59 | +26.86% | 24 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $43 | $26.08 | +64.88% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $232 → $256 | $271.62 | -5.75% | 16 | Dec 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $203 → $210 | $239.40 | -12.28% | 18 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $6 | $1.22 | +391.80% | 21 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 → $342 | $331.50 | +3.17% | 14 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $349 → $361 | $337.22 | +7.05% | 37 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $921.38 | - | 45 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7.5 | $6.47 | n/a | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $542 | $557.96 | n/a | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $131.13 | n/a | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.67 | n/a | 1 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $4.80 | n/a | 16 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7.5 | $13.25 | n/a | 1 | Jan 5, 2022 |
Cardinal Health
Aug 11, 2026
Maintained: Buy
Price Target: $240 → $292
Current: $248.61
Upside: +17.45%
GoodRx Holdings
Aug 6, 2026
Maintained: Buy
Price Target: $5
Current: $3.53
Upside: +41.64%
Medpace Holdings
Jul 23, 2026
Maintained: Hold
Price Target: $490 → $620
Current: $593.39
Upside: +4.48%
Progyny
Jul 22, 2026
Maintained: Buy
Price Target: $38
Current: $26.61
Upside: +42.80%
Align Technology
Jun 30, 2026
Reiterated: Buy
Price Target: $230
Current: $159.86
Upside: +43.88%
Certara
Jun 16, 2026
Reiterated: Buy
Price Target: $13 → $8
Current: $8.13
Upside: -1.60%
DENTSPLY SIRONA
Jun 12, 2026
Maintained: Hold
Price Target: n/a
Current: $11.43
Upside: -
Medline
Jun 12, 2026
Maintained: Buy
Price Target: $56 → $52
Current: $36.59
Upside: +42.12%
ICON Public Limited Company
May 28, 2026
Maintained: Hold
Price Target: $125 → $145
Current: $163.58
Upside: -11.36%
Doximity
May 15, 2026
Rated: Buy
Price Target: $79 → $25
Current: $27.10
Upside: -7.75%
Apr 16, 2026
Maintained: Hold
Price Target: n/a
Current: $27.82
Upside: -
Mar 24, 2026
Reiterated: Buy
Price Target: $98
Current: $97.20
Upside: +0.82%
Feb 24, 2026
Reiterated: Hold
Price Target: $87
Current: $90.86
Upside: -4.25%
Feb 6, 2026
Upgraded: Buy
Price Target: $35
Current: $27.59
Upside: +26.86%
Feb 2, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $26.08
Upside: +64.88%
Dec 14, 2025
Maintained: Buy
Price Target: $232 → $256
Current: $271.62
Upside: -5.75%
Oct 22, 2025
Reiterated: Buy
Price Target: $203 → $210
Current: $239.40
Upside: -12.28%
Oct 9, 2025
Rated: Hold
Price Target: $5 → $6
Current: $1.22
Upside: +391.80%
Oct 8, 2025
Reiterated: Buy
Price Target: $323 → $342
Current: $331.50
Upside: +3.17%
Oct 6, 2025
Maintained: Buy
Price Target: $349 → $361
Current: $337.22
Upside: +7.05%
Oct 6, 2025
Maintained: Buy
Price Target: n/a
Current: $921.38
Upside: -
Jul 30, 2025
Reiterated: Hold
Price Target: $7.5
Current: $6.47
Upside: n/a
Dec 20, 2024
Reiterated: Buy
Price Target: $542
Current: $557.96
Upside: n/a
Sep 4, 2024
Maintained: Hold
Price Target: n/a
Current: $131.13
Upside: n/a
Jul 8, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.67
Upside: n/a
Jun 14, 2023
Maintained: Buy
Price Target: $22
Current: $4.80
Upside: n/a
Jan 5, 2022
Maintained: Hold
Price Target: $7.5
Current: $13.25
Upside: n/a